Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia.
作者信息
Wierda William G, Byrd John C, O'Brien Susan, Coutre Steven, Barr Paul M, Furman Richard R, Kipps Thomas J, Burger Jan A, Stevens Don A, Sharman Jeff, Ghia Paolo, Flinn Ian W, Zhou Cathy, Ninomoto Joi, James Danelle F, Tam Constantine S
机构信息
University of Texas, MD Anderson Cancer Center, Houston, TX.
The Ohio State University Medical Center, Columbus, OH.
出版信息
Br J Haematol. 2019 Jul;186(1):184-188. doi: 10.1111/bjh.15791. Epub 2019 Feb 10.
PMID:30740654
Abstract
摘要
Zotero 插件